Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
Valeant Pharmaceuticals International (NYSE: VRX) reported final results for its Phase IIb dose-finding clinical trial for taribavirin, a prodrug of ribavirin which is in development for the treatment of chronic hepatitis C in conjunction with a pegylated interferon. The study in treatment naive genotype 1 infected subjects was of standard design, consisting of 48 weeks of treatment with a 24-week follow-up period. It explored three weight-based doses of taribavirin: 20 mg/kg, 25 mg/kg and 30 mg/kg vs. ribavirin 800-1400 mg/day. Throughout the 72-week trial, all doses of taribavirin demonstrated comparable efficacy (sustained virologic response (SVR)) to ribavirin with consistently lower levels of anemia. In addition, relapse rates in the 25 mg/kg and 30 mg/kg arms were comparable with the ribavirin arm; supporting the premise that higher dose weight-based taribavirin may be as effective as weight based ribavirin. Valeant plans to present the full final data at the American Association for the Study of Liver Disease (AASLD) later this year.
drugs without prescription
Media Looks At County-Level HIV, AIDS Map Data
Major population centers such as those in New York and California have the highest numbers of HIV cases, however, many of the areas that have the highest rates of people with HIV are in the South, according to data from an online mapping tool launched by the National Minority Quality Forum yesterday, the AP/Minneapolis Star Tribune reports. The map, which is the first tool of its kind to look at HIV and AIDS cases on a county level, is based on 2006 data collected from states and cross-checked with CDC data. According to the mapping tool, of the 48 counties with the highest HIV prevalence rates, 25 are in Georgia. In addition, Florida, Georgia, South Carolina and Virginia have the highest prevalence rates for HIV cases that have progressed to AIDS (Stobbe, AP/Minneapolis Star Tribune, 6/22). In Virginia, Richmond, Petersburg and Norfolk were among the nation"s urban areas hardest hit by HIV/AIDS (Smith, Richmond Times-Dispatch, 6/23). Three metro counties in Kansas City, Mo., have HIV and AIDS rates that are higher than about 80 percent of counties nationwide, according to the data, NBC Action News reports (Ptacek, NBC Action News, 6/22).
News of the day
Poniard Rally To Continue: Strong Efficacy And Safety Data From Picoplatin
Poniard announced positive Phase II data from its two trials in CRC and CRPC with picoplatin this morning, including efficacy that was comparable to the current standard of care, with a significantly improved safety profile. We believe that these data provide further evidence of picoplatin"s favorable efficacy and safety profile in two more large oncology markets, in addition to SCLC, and position picoplatin as a platform treatment that can provide solutions in multiple oncology settings. We believe that given these data from CRC and CRPC, in addition to the anticipated Phase III SPEAR data in SCLC, will attract the interest of multiple players and we expect that Poniard will be able to at least secure a large pharma partnership sometime this summer, unless a company like Sanofi (SNY Not Rated), Takeda (TKD Not rated), or Bristol-Myers Squibb (BMY Not Rated) decide to step in and acquire the whole company, for rights to both the IV and oral version of picoplatin.
Public Health

UnitedHealth Group Offers 15 Recommendations To Reduce Federal Health Spending By $540B Over 10 Years

UnitedHealth Group"s Center for Health Reform and Modernization on Wednesday suggested 15 steps that could be taken to save $540 billion in federal in health care costs over the next 10 years, the AP/Seattle Post-Intelligencer reports (Werner, AP/Seattle Post-Intelligencer, 5/27). Simon Stevens, head of the center, said that the report "puts some flesh on the bones" of the pledge made by health care industry groups earlier this month to cut health care costs, noting that the recommendations already are being used by UnitedHealth to reduce costs and can be applied to Medicare (Reuters, 5/27).The recommended steps include: *Providing patients with incentives for going to high-quality, efficient physicians; *Reducing unnecessary care; *Granting physicians incentives for providing comprehensive and preventive care; *Providing nurse practitioners at nursing homes to manage illness and reduce avoidable hospitalizations to save $166 billion; *Using evidence-based care management with preventive care to reduce avoidable hospitalizations and save $102 billion; *Analyzing claims before they are paid to prevent duplicate billing and other administrative errors to save $57 billion (CongressDaily, 5/27); and *Reducing the use of advanced imaging technologies to save $13 billion (AP/Seattle Post-Intelligencer, 5/27)."We are issuing (the recommendations) as a constructive contribution to the debate on how national health reform can proceed," Stevens said. He added, "What we know is there is a huge variation in cost and quality across the health care system," and the proposed steps are "some of the practical techniques that help us get a grip on that" (Diaz, Minneapolis Star Tribune, 5/27). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009